Nuclear energy stocks are back in focus because the power market suddenly looks tighter, more strategic, and more valuable than it did a few years ago. Electricity demand is reaccelerating after a long period of relative stagnation, while AI infrastructure and data-center buildouts are pushing large buyers toward always-on, low-carbon power sources. That backdrop has improved sentiment not just for reactor owners, but across the full nuclear value chain. A major signal came in January 2026, when Meta announced 20-year power agreements tied to three Vistra nuclear plants while also backing SMR projects.
The bull case has several layers. Existing reactor operators and regulated utilities offer nearer-term cash flow, life-extension potential, and direct exposure to rising demand for dependable baseload generation. Uranium miners and fuel-cycle specialists are more leveraged to supply tightness, enrichment bottlenecks, and domestic energy-security policy. Then there are advanced nuclear and SMR developers, which carry the highest execution risk but also the most upside if commercialization milestones are hit. In other words, “nuclear stocks” are no longer one bucket; they are a set of distinct business models responding to the same macro tailwind.
This list ranks seven US-listed nuclear-related stocks in countdown order, from #7 to the best pick at #1, based on investment quality within today’s market setup. That means balancing business relevance to the theme with profitability, growth, earnings consistency, valuation context, and analyst sentiment. Some names here are steadier operators, while others are more speculative expressions of the same trend. The countdown format matters: the strongest overall fit for May 2026 appears last.
For this screen, we focused on US-listed nuclear energy stocks and adjacent names with market capitalizations above $500 million, then ranked them primarily on investment quality rather than pure upside. We weighed each company’s business exposure to nuclear power, profitability profile, growth trends, earnings execution, analyst sentiment, and our composite quality grade. Because this is a monthly refresh list, we emphasize durable operating and financial metrics over day-to-day price action. The names below are presented as a countdown, so the best overall pick is revealed at #1.
What they do. The company produces and sells energy products and services across the United States through five segments: Mid-Atlantic, Midwest, New York, ERCOT, and Other Power Regions. Constellation serves utilities, municipalities, cooperatives, and commercial, industrial, public-sector, and residential customers, and it operates approximately 31,676 megawatts of generating capacity spanning nuclear, wind, solar, natural gas, and hydroelectric assets.
Why it fits. Constellation is one of the clearest large-cap ways to express the nuclear baseload theme because it already owns a large operating fleet rather than merely promising future capacity. In a market where hyperscalers and large commercial buyers increasingly want round-the-clock low-carbon power, an established generator with a broad customer base and existing nuclear output is strategically well positioned.
Numbers that matter. Constellation generated $29.87 billion in revenue and $7.96 billion in EBITDA, with a 23.3% gross margin, 21.86% operating margin, and 12.69% net margin. Profitability is solid, with ROE of 16.1% and ROA of 4.2%. Growth has also been strong, with revenue up 63.8% year over year and earnings growth of 10.91%, while trailing and forward P/E ratios sit near 22.5 and 22.27, respectively. The catch is valuation discipline: its composite quality profile is only a B, with weak component scores on both P/E and price-to-book.
Recent momentum. The latest quarter was encouraging, with EPS of 2.74 versus a 2.27 estimate, a 20.7% surprise. Still, the longer record is less clean, with earnings beats in 4 of the last 8 quarters, including misses of 0.4% in February 2026 and 2.6% in November 2025. Analyst sentiment is respectable but not aggressive, with a 4.375 consensus and a split of 2 Buy and 4 Hold ratings.
What they do. The company is a regulated US energy utility operating through Electric Utilities and Infrastructure and Gas Utilities and Infrastructure. Duke generates, transmits, distributes, and sells electricity across the Southeast and Midwest, and its generation mix includes coal, hydroelectric, natural gas, oil, renewables, and nuclear fuel.
Why it fits. Duke is a lower-volatility way to participate in the nuclear theme because its exposure comes through an established regulated utility model rather than a pure-play fuel or development story. For investors who want nuclear as part of a broader grid and infrastructure portfolio, Duke offers direct nuclear generation within a diversified electric system and a business model tied to customer demand growth.
Numbers that matter. Duke posted $32.72 billion in revenue and $16.48 billion in EBITDA, with a 51.0% gross margin, 25.51% operating margin, and 15.71% net margin. Profitability is steady rather than spectacular, with ROE of 9.66% and ROA of 2.78%. Growth is modest but positive, with revenue up 11.3% year over year and earnings growth of 12.0%, while trailing and forward P/E ratios are 18.90 and 18.05. The main quality drag is leverage and valuation sensitivity, reflected in weaker component scores for debt-to-equity, P/E, and price-to-book.
Recent momentum. Execution has been notably consistent. Duke has beaten EPS estimates in 7 of the last 8 quarters, including a 9.0% beat in May 2026 and a 0.7% beat in February 2026. Analysts remain constructive but measured, with a 3.8 consensus and a breakdown of 2 Buy and 11 Hold ratings, which fits the stock’s profile as a steadier utility exposure rather than a high-beta nuclear trade.
What they do. The company is an integrated retail electricity and power generation business serving about 5 million customers. Vistra operates across Retail, Texas, East, West, and Asset Closure, and it has approximately 44,000 megawatts of generation capacity spanning natural gas, nuclear, coal, solar, and battery energy storage.
Why it fits. Vistra sits close to the center of the current nuclear narrative because it combines existing nuclear generation with a broad merchant and retail power platform. The theme context specifically highlighted Meta’s January 2026 announcement of 20-year agreements tied to three Vistra nuclear plants, which reinforces the company’s relevance as Big Tech turns nuclear demand into direct procurement.
Numbers that matter. Vistra generated $19.45 billion in revenue and $6.79 billion in EBITDA, with a 38.6% gross margin, 26.58% operating margin, and 11.53% net margin. Profitability ratios are strong on paper, including ROE of 42.9% and ROA of 6.02%. Revenue growth was robust at 43.4% year over year, but earnings growth was negative 52.3%, which helps explain why the stock ranks only mid-pack on investment quality despite a forward P/E of 14.75 versus a trailing 22.21. Composite scoring also flags debt, valuation, and book-value concerns.
Recent momentum. The latest quarter was a major upside surprise, with EPS of 2.87 against a 1.28 estimate, a 124.2% beat. But the broader pattern is uneven: Vistra has beaten in only 3 of the last 8 quarters, with several large misses, including a 76.5% miss in February 2026 and a 251.7% miss in May 2025. Analysts are more bullish than the quality grade suggests, with a 4.2778 consensus and 5 Buy versus 2 Hold ratings.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
What they do. The company supplies nuclear fuel components through two segments: Low-Enriched Uranium and Technical Solutions. Centrus sells separative work units, uranium concentrates, conversion products, and enriched uranium products to utilities operating nuclear plants, while also providing technical, manufacturing, engineering, and operations services to public- and private-sector customers.
Why it fits. Centrus is one of the more direct fuel-cycle plays on this list. If the nuclear theme broadens from power procurement into concerns about domestic supply security, enrichment capacity, and the back end of the fuel chain, Centrus becomes strategically important in a way that reactor owners alone do not capture.
Numbers that matter. Centrus produced $452.3 million in revenue and $34.2 million in EBITDA, with a 25.7% gross margin and a 13.4% net margin, though operating margin was slightly negative at -0.26%. ROE was 12.25%, but ROA was just 0.79%, showing how narrow the asset-level profitability still is. Revenue growth was 4.9% year over year, while earnings growth fell 71.9%, and the stock trades at a trailing P/E of 62.89 with a forward P/E of 66.67. That combination of strategic relevance and stretched valuation is why it lands in the middle rather than near the top.
Recent momentum. Quarterly execution has been volatile but often dramatic. The March 2026 report delivered EPS of 1.05 versus a 0.27 estimate, a 288.9% surprise, and Centrus has beaten in 5 of the last 8 quarters, including a 1,425.0% surprise in May 2025. Analyst coverage is limited, with a 4.5 consensus based on 1 Buy and 2 Hold ratings, which suggests interest is real but still relatively narrow.
What they do. The company is an independent power producer and infrastructure business that sells electricity, capacity, and ancillary services into US wholesale markets. Talen owns and operates approximately 13.1 gigawatts of power infrastructure, with generation from nuclear, fossil, oil, natural gas, and coal plants.
Why it fits. Talen is a high-operating-leverage way to play rising power demand, especially where nuclear generation can support tight wholesale markets and data-center-driven load growth. Unlike a regulated utility, its economics are more directly tied to merchant power conditions, which can make it a stronger thematic vehicle when market pricing is favorable.
Numbers that matter. Talen generated $3.24 billion in revenue and $654 million in EBITDA, with a 40.1% gross margin and 17.24% operating margin, but a net margin of -0.65%. ROA was positive at 1.94%, while ROE was negative 1.86%, reflecting the still-messy bottom-line profile. Revenue growth was exceptionally strong at 96.7% year over year and earnings growth was 34.5%, while forward P/E stands at 13.79 even though trailing earnings remain negative. The tension here is obvious: operating momentum is strong, but the composite quality grade is weak across the board.
Recent momentum. Recent earnings have been better than the headline quality score implies. Talen has beaten estimates in 6 of the last 8 quarters, including a 2.9% beat in May 2026 and a 1.2% beat in March 2026, though there were also severe misses in mid-2025. Analysts are notably bullish, with a 4.6667 consensus and 3 Buy ratings, making this one of the more controversial names on the list.
Pick #2Subscribers only
Subscribers see this pick's full breakdown — investment thesis, key financial metrics, recent earnings execution, and analyst consensus.
Subscribers get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
This monthly list starts with a universe of US-listed nuclear energy and nuclear-adjacent stocks with market capitalizations above $500 million. We then rank candidates using a quality-first framework that considers business relevance to the nuclear theme, profitability, growth, earnings consistency, valuation context, analyst sentiment, and our composite quality grade. Existing reactor operators, regulated utilities, uranium suppliers, fuel-cycle specialists, and advanced-reactor developers can all qualify if their business models are meaningfully tied to nuclear power. Because the list refreshes regularly, rankings can change as earnings reports, consensus views, and operating metrics evolve.
